MED17.11 - Mouse DRG Cell Line with Properties of Nociceptors

MED17.11 cells have the potential to replace or reduce the use of primary DRG culture.
Technology No.

A DRG progenitor cell line from the Immortomouse.

MED17.11 cells have the potential to replace or reduce the use of primary DRG culture in sensory, pain and developmental research by providing a simple model to study neurite outgrowth, the developmental specification and peripheral sensitisation of DRG neurons.

For academic licences we charge a £200 packaging fee and request that licensees arrange for delivery.  Recipients are responsible for paying any import duties that are incurred.

  • swap_vertical_circlemode_editAuthors (1)
    Dr Mohammed Nassar
  • swap_vertical_circlelibrary_booksReferences (1)
    1. Nassar, Drundy, Holley, Chetrit, Doran (2015), Mouse DRG Cell Line with Properties of Nociceptors, Plos One
  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    MED17.11 - Mouse DRG Cell Line with Properties of Nociceptors.pdf
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
Non-Commercial/Academic - Med17.11 (with Fed-Ex account)
Select this option if you are arranging for your courier to collect the materials (£200 charge)

Term: perpetual

Free of charge

Non-Commercial/Academic - med17.11 (without Fed-Ex account)
Select this option if Sheffield is arranging for delivery (£320 charge)

Term: perpetual

Free of charge

Commercial Licence - Med 17.11
6-month trial licence for commercial organisations

Term: 6 months

Price per unit:
From £5,000.00 excl. VAT

Commercial Licence - Med 17.11
perpetual licence for commercial organisations

Term: perpetual

Price per unit:
From £20,000.00 excl. VAT